scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1161/01.RES.0000137876.28454.64 |
P698 | PubMed publication ID | 15297385 |
P50 | author | Ann Marie Schmidt | Q89261684 |
P2093 | author name string | Jean-Luc Wautier | |
P433 | issue | 3 | |
P921 | main subject | endothelium | Q111140 |
P304 | page(s) | 233-238 | |
P577 | publication date | 2004-08-01 | |
P1433 | published in | Circulation Research | Q2599020 |
P1476 | title | Protein glycation: a firm link to endothelial cell dysfunction | |
P478 | volume | 95 |
Q38116590 | AGEs, contributors to placental bed vascular changes leading to preeclampsia |
Q38214954 | Abnormal adhesion of red blood cells in polycythemia vera: a prothrombotic effect? |
Q35027646 | Activation of AMP-activated protein kinase prevents lipotoxicity in retinal pericytes |
Q42625886 | Activation of endothelial cells in conduit veins of dogs with heart failure and veins of normal dogs after vascular stretch by acute volume loading |
Q51369502 | Adipose tissue expression of interleukin-18 mRNA is elevated in subjects with metabolic syndrome and independently associated with fasting glucose. |
Q58610857 | Advanced Glycation End Products profiling uncovers abiotic stress specific target proteins in Arabidopsis |
Q36671087 | Advanced glycation end products acutely impair ca(2+) signaling in bovine aortic endothelial cells |
Q36069797 | Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation |
Q37633629 | Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the Src-family kinase activation. |
Q35660934 | Advanced glycation end products of DNA: quantification of N2-(1-Carboxyethyl)-2'-deoxyguanosine in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry |
Q34410712 | Advanced glycation end products of bovine serum albumin-induced endothelial-to-mesenchymal transition in cultured human and monkey endothelial cells via protein kinase B signaling cascades |
Q36062228 | Advanced-glycation end products in insulin-resistant states |
Q36716474 | Aldehyde metabolism in the cardiovascular system. |
Q38516531 | Altered phenotype and gene transcription in endothelial cells, induced by Plasmodium falciparum-infected red blood cells: pathogenic or protective? |
Q45776839 | Amyloid deposition and influx transporter expression at the blood-brain barrier increase in normal aging |
Q36714114 | Arterial Stiffness, Lipoprotein Particle Size, and Lipoprotein Particle Concentration in Children with Type 1 Diabetes |
Q46101673 | Association between the receptor for advanced glycation end products gene polymorphisms and coronary artery disease |
Q57825178 | Associations of Serum Levels of Advanced Glycation end Products with Nutrition Markers and Anemia in Patients with Chronic Kidney Disease |
Q35757154 | Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy |
Q53231716 | C-peptide reduces high-glucose-induced apoptosis of endothelial cells and decreases NAD(P)H-oxidase reactive oxygen species generation in human aortic endothelial cells. |
Q46691934 | Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells |
Q37934954 | Cell signaling and receptors in toxicity of advanced glycation end products (AGEs): α-dicarbonyls, radicals, oxidative stress and antioxidants |
Q36687957 | Cellular mechanisms and signalling pathways activated by high glucose and AGE-albumin in the aortic endothelium |
Q36062252 | Cellular mechanisms and treatment of diabetes vascular complications converge on reactive oxygen species |
Q39137289 | Central Role of Metabolism in Endothelial Cell Function and Vascular Disease |
Q36776710 | Chronic hyperglicemia and nitric oxide bioavailability play a pivotal role in pro-atherogenic vascular modifications. |
Q43057657 | Combined immunoelectron microscopic and computer-assisted image analyses to detect advanced glycation end-products in human myocardium. |
Q36362707 | Commonality in chronic inflammatory diseases: periodontitis, diabetes, and coronary artery disease |
Q33511919 | Continuous, non-invasive measurement of the haemodynamic response to submaximal exercise in patients with diabetes mellitus: evidence of impaired cardiac reserve and peripheral vascular response. |
Q38300037 | Cytoprotective effects of N,N,N-trimethylsphingosine during ischemia- reperfusion injury are lost in the setting of obesity and diabetes |
Q38676080 | Declining Skeletal Muscle Function in Diabetic Peripheral Neuropathy |
Q35043454 | Decreased cerebrovascular brain-derived neurotrophic factor-mediated neuroprotection in the diabetic brain |
Q37733102 | Dietary hyperglycemia, glycemic index and metabolic retinal diseases |
Q34927281 | Elevated levels of procoagulant plasma microvesicles in dialysis patients. |
Q49787990 | Endothelial Cell Metabolism. |
Q52674867 | Endothelial Dysfunction in Type 2 Diabetes Mellitus. |
Q35234625 | Endothelial cell metabolism in normal and diseased vasculature |
Q36201692 | Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. |
Q46565372 | Erythroid adhesion molecules in sickle cell disease: effect of hydroxyurea |
Q64083177 | Experimental Hyperglycemia Alters Circulating Concentrations and Renal Clearance of Oxidative and Advanced Glycation End Products in Healthy Obese Humans |
Q34343547 | Exploring the human plasma proteome for humoral mediators of remote ischemic preconditioning--a word of caution |
Q37163425 | Expression of the receptor for advanced glycation end products in oligodendrocytes in response to oxidative stress |
Q39378677 | Glucose metabolite glyoxal induces senescence in telomerase-immortalized human mesenchymal stem cells |
Q35166333 | Glycated albumin produced in diabetic hyperglycemia promotes monocyte secretion of inflammatory cytokines and bacterial adherence to epithelial cells |
Q44089119 | Glycated collagen and altered glucose increase endothelial cell adhesion strength. |
Q39649360 | Glycation of Liver Cystatin: Implication on its Structure and Function |
Q41265501 | Glycation of high-density lipoprotein triggers oxidative stress and promotes the proliferation and migration of vascular smooth muscle cells |
Q38197359 | Glyoxalase I (Glo1) and its metabolites in vascular disease |
Q35080475 | Glyoxalase I reduces glycative and oxidative stress and prevents age-related endothelial dysfunction through modulation of endothelial nitric oxide synthase phosphorylation |
Q58477477 | HUVECs from newborns with a strong family history of diabetes show diminished ROS synthesis in the presence of high glucose concentrations |
Q34507243 | Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study |
Q36010304 | Hyperglycemia promotes tissue plasminogen activator-induced hemorrhage by Increasing superoxide production |
Q36893819 | Hypochlorite-modified albumin colocalizes with RAGE in the artery wall and promotes MCP-1 expression via the RAGE-Erk1/2 MAP-kinase pathway |
Q37673039 | Increased levels of circulating advanced glycation end-products in menopausal women with osteoporosis |
Q42268694 | Increased tumor necrosis factor-α, cleaved caspase 3 levels and insulin receptor substrate-1 phosphorylation in the β₁-adrenergic receptor knockout mouse |
Q26745509 | Insulin signalling and glucose transport in the ovary and ovarian function during the ovarian cycle |
Q37180237 | Insulin treatment enhances the myocardial angiogenic response in diabetes |
Q47230788 | Iron reduction response and demographic differences between diabetics and non-diabetics with cardiovascular disease entered into a controlled clinical trial |
Q84987537 | Is there any association between GLY82 ser polymorphism of rage gene and Turkish diabetic and non diabetic patients with coronary artery disease? |
Q36773203 | Left atrium volume index is influenced by aortic stiffness and central pulse pressure in type 2 diabetes mellitus patients: a hemodynamic and echocardiographic study |
Q39565171 | MIR221/MIR222-driven post-transcriptional regulation of P27KIP1 and P57KIP2 is crucial for high-glucose- and AGE-mediated vascular cell damage |
Q38882106 | Manipulating Angiogenesis by Targeting Endothelial Metabolism: Hitting the Engine Rather than the Drivers-A New Perspective? |
Q34510507 | Meta-analysis of RAGE gene polymorphism and coronary heart disease risk |
Q39373990 | Metabolic Regulation of Angiogenesis in Diabetes and Aging |
Q61783676 | Metabolic systems analysis of LPS induced endothelial dysfunction applied to sepsis patient stratification |
Q42440485 | NOX1 abet mesangial fibrogenesis via iNOS induction in diabetes |
Q35113743 | Oral adsorbent AST-120 decreases serum levels of AGEs in patients with chronic renal failure |
Q29615423 | Oxidative Stress and Diabetic Complications |
Q37375332 | Oxidative stress in diabetes: implications for vascular and other complications |
Q46395512 | Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients |
Q37423137 | Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction |
Q40200491 | Plasma methylglyoxal and glyoxal are elevated and related to early membrane alteration in young, complication-free patients with Type 1 diabetes |
Q42520665 | Platelet free cytosolic calcium concentration during ageing of type 2 diabetic patients |
Q35174193 | Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspective |
Q79999725 | Postprandial hyperglycemia alters inflammatory and hemostatic parameters |
Q46093171 | Preserved residual renal function is associated with lower oxidative stress in peritoneal dialysis patients. |
Q37415313 | Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase |
Q26859449 | Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease |
Q35803421 | Protection from diabetes-induced peripheral sensory neuropathy--a role for elevated glyoxalase I? |
Q35413473 | Protein glycosylation in cancer |
Q34118916 | Proteomic identification of carbonylated proteins and their oxidation sites |
Q60732952 | RAGE Gene Polymorphisms in Patients with Multiple Sclerosis |
Q43935666 | RAGE mediates the inactivation of nAChRs in sympathetic neurons under high glucose conditions |
Q54124829 | RAGE-dependent potentiation of TRPV1 currents in sensory neurons exposed to high glucose. |
Q43135445 | Radiation oxygen biology with pulse electron paramagnetic resonance imaging in animal tumors |
Q36842628 | Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes |
Q37400729 | Reductive metabolism of AGE precursors: a metabolic route for preventing AGE accumulation in cardiovascular tissue |
Q36608513 | Relationship between advanced glycation end products and plaque progression in patients with acute coronary syndrome: the JAPAN-ACS sub-study |
Q35923917 | Rho GTPases and leucocyte-induced endothelial remodelling |
Q33837549 | Ribose sugars generate internal glycation cross-links in horse heart myoglobin |
Q38086104 | Role of microangiopathy in diabetic cardiomyopathy |
Q37306295 | Roles of oxidants, nitric oxide, and asymmetric dimethylarginine in endothelial function |
Q82631349 | Serum Pentosidine, An Advanced Glycation End Product, Indicates Poor Outcomes After Acute Ischemic Stroke |
Q92598444 | Serum alkaline phosphatase levels correlate with long-term mortality solely in peritoneal dialysis patients with residual renal function |
Q37504674 | Sexual dimorphism in the aging kidney: differences in the nitric oxide system |
Q61845347 | Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammation |
Q35068413 | Soluble receptor for advanced glycation end products as an indicator of pulmonary vascular injury after cardiac surgery |
Q34412546 | Specific Binding of Red Blood Cells to Endothelial Cells Is Regulated by Nonadsorbing Macromolecules |
Q36967504 | Sphingolipid therapy in myocardial ischemia-reperfusion injury |
Q37017403 | Studies on free radicals, antioxidants, and co-factors |
Q37685401 | The (pro)renin receptor mediates constitutive PLZF-independent pro-proliferative effects which are inhibited by bafilomycin but not genistein |
Q90152657 | The Bewildering Effect of AMPK Activators in Alzheimer's Disease: Review of the Current Evidence |
Q57066613 | The Main Determinants of Diabetes Mellitus Vascular Complications: Endothelial Dysfunction and Platelet Hyperaggregation |
Q36203901 | The discovery of glycated hemoglobin: a major event in the study of nonenzymatic chemistry in biological systems |
Q92131608 | The lichen symbiosis re-viewed through the genomes of Cladonia grayi and its algal partner Asterochloris glomerata |
Q37100347 | The mechanisms underlying fructose-induced hypertension: a review |
Q90398573 | The relationship between pancreatic cancer and type 2 diabetes: cause and consequence |
Q38241689 | The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach |
Q37044976 | The roles of hyperglycaemia and oxidative stress in the rise and collapse of the natural protective mechanism against vascular endothelial cell dysfunction in diabetes |
Q35780015 | The ɛ-Amino Group of Protein Lysine Residues Is Highly Susceptible to Nonenzymatic Acylation by Several Physiological Acyl-CoA Thioesters |
Q33765479 | Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress |
Q47572183 | Therapeutic effect of sunitinib on diabetes mellitus related ovarian injury: an experimental rat model study |
Q37895528 | Therapeutic neovascularization for coronary disease: current state and future prospects |
Q26752302 | Understanding the Causes and Implications of Endothelial Metabolic Variation in Cardiovascular Disease through Genome-Scale Metabolic Modeling |
Q60047178 | Urothelial Senescence in the Pathophysiology of Diabetic Bladder Dysfunction-A Novel Hypothesis |
Q46044501 | Vascular biomarkers in the metabolic syndrome |
Q46380847 | Vasculopathy in type 2 diabetes mellitus: role of specific angiogenic modulators |
Q46137989 | Visfatin and endogenous secretory receptor for advanced glycation end-products in diabetic type 2 and non-diabetic patients undergoing intermittent hemodialysis |
Q83130963 | [The influence of diabetes mellitus on male reproductive function: a poorly investigated aspect of male infertility] |
Search more.